Aanjaneya Lifecare is currently trading at Rs. 765.70, up by 2.75 points or 0.36% from its previous closing of Rs. 762.95 on the BSE.
The scrip opened at Rs. 760.95 and has touched a high and low of Rs. 772.60 and Rs. 735.50 respectively. So far 2739 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 850.70 on 18-Jan-2013 and a 52 week low of Rs. 360.85 on 10-May-2012.
Last one week high and low of the scrip stood at Rs. 784.00 and Rs. 723.00 respectively. The current market cap of the company is Rs. 1063.34 crore.
The promoters holding in the company stood at 46.79% while Institutions and Non-Institutions held 1.06% and 52.15% respectively.
Aanjaneya Lifecare has reported results for third quarter ended December 31, 2012.
The company has reported 13.92% jump in its net profit at Rs 10.45 crore for the quarter as compared to Rs 12.14 crore for the same quarter in the previous year. Total income from operation of the company has increased by 35.58% at Rs 145.86 crore for quarter under review as compared to Rs 107.58 crore for the quarter ended December 31, 2011.
Aanjaneya Lifecare is a leading research based integrated pharmaceutical company with established research, manufacturing and marketing capabilities. It is R&D focused, has a multi product portfolio with state of the art manufacturing facilities, and is set to become a marketing conglomerate across the globe.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: